Warp Sciences, founded by former OpenAI executives, raises $215 million to build an AI drug research laboratory
Warp Sciences, co-founded by former executives from companies including OpenAI and Meta, has completed a $215 million financing round and will build a chemistry research facility in the United States, using AI and robotics to help pharmaceutical and biotechnology companies develop drugs. The company operates as a chemistry contract research organization (CRO), initially focusing on lead compound optimization through analog synthesis, with chemists guiding experiments and experimental data used to train AI models. The round was led by Lightspeed, with participation from Premji Invest, Mayfield, IVP, Lux, Conviction, Menlo Ventures, 01 Advisors and others; angel investors include Brian Armstrong, Ion Stoica and Dylan Field.
Warp Sciences, co-founded by former executives from companies including OpenAI and Meta, has completed a $215 million financing round and will build a chemistry research facility in the United States, using AI and robotics to help pharmaceutical and biotechnology companies develop drugs. The company operates as a chemistry contract research organization (CRO), initially focusing on lead compound optimization through analog synthesis, with chemists guiding experiments and experimental data used t
Matched fieldsBody


